Cargando…

Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries

Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worakunphanich, Wiwan, Youngkong, Sitaporn, Suwankesawong, Wimon, Anderson, Claire, Thavorncharoensap, Montarat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028008/ https://www.ncbi.nlm.nih.gov/pubmed/35457318 http://dx.doi.org/10.3390/ijerph19084447

Ejemplares similares

Thai stakeholders’ awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study
por: Worakunphanich, Wiwan, et al.
Publicado: (2023)

Economic burden of childhood diarrhea in Burundi
por: Niyibitegeka, Fulgence, et al.
Publicado: (2021)

Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study
por: Haider, Mohammad Sabbir, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2021)

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis
por: Yoopetch, Panida, et al.
Publicado: (2023)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database
por: Suwankesawong, Wimon, et al.
Publicado: (2014)

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
por: Falzon, Dennis, et al.
Publicado: (2014)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review
por: Gurav, Yogesh Kirshnarao, et al.
Publicado: (2022)

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions
por: Youngkong, Sitaporn, et al.
Publicado: (2011)

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions
por: Youngkong, Sitaporn, et al.
Publicado: (2011)

Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi
por: Hezagira, Nina, et al.
Publicado: (2022)

Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method
por: Prasert, Vanida, et al.
Publicado: (2022)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse Drug Reactions in Hospitalised Children in Germany Are Decreasing: Results of a Nine Year Cohort-Based Comparison
por: Oehme, Ann-Kathrin, et al.
Publicado: (2012)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
por: Marsh, Kevin, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Diagnostic Tests for Para-Aortic Lymph Node Detection in Locally Advanced Cervical Cancer
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
por: Briones, Jamaica Roanne, et al.
Publicado: (2020)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

Treatment cost and costing model of obstetric complications at a hospital in Myanmar
por: Shwe, A. Thi Win, et al.
Publicado: (2019)

Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic
por: Kategeaw, Warittakorn, et al.
Publicado: (2022)

The economic impact of alcohol consumption: a systematic review
por: Thavorncharoensap, Montarat, et al.
Publicado: (2009)

Economic impact of medical genetic testing on clinical applications in Thailand
por: Jittikoon, Jiraphun, et al.
Publicado: (2020)

Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences
por: Noparatayaporn, Prapaporn, et al.
Publicado: (2021)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023)

Factors affecting health-related quality of life in Thai children with thalassemia
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
por: Riewpaiboon, Arthorn, et al.
Publicado: (2010)

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
por: Thavorncharoensap, Montarat, et al.
Publicado: (2013)

Adverse Drug Reaction Reporting by Patients in 12 European Countries
por: Valinciute-Jankauskiene, Agne, et al.
Publicado: (2021)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?
por: Baltussen, Rob, et al.
Publicado: (2023)

Health app policy: international comparison of nine countries’ approaches
por: Essén, Anna, et al.
Publicado: (2022)

Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment
por: Teerawattananon, Yot, et al.
Publicado: (2016)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic costs of obesity in Thailand: a retrospective cost-of-illness study
por: Pitayatienanan, Paiboon, et al.
Publicado: (2014)

Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
por: Due, Ong The, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t06glaqslvf2a06f4a4g2lg33e